Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Funmi Ajayi

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Problems in Dermatology|February 18, 2011
Products used on female genital mucosaMiranda A Farage, Lisa Lennon, Funmi Ajayi
Global Journal of Health Science|September 18, 2012
Design principles to accommodate older adultsMiranda A Farage, Kenneth W Miller, Funmi Ajayi, et al.
Antimicrobial Agents and Chemotherapy|November 4, 2009
Dose escalation study of the safety, tolerability, and pharmacokinetics of nemonoxacin (TG-873870), a novel potent broad-spectrum nonfluorinated quinolone, in healthy volunteersLuke Lin, Li-Wen Chang, Cheng-Yuan Tsai, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Problems in Dermatology|February 18, 2011
Products used on female genital mucosaMiranda A Farage, Lisa Lennon, Funmi Ajayi
Global Journal of Health Science|September 18, 2012
Design principles to accommodate older adultsMiranda A Farage, Kenneth W Miller, Funmi Ajayi, et al.
Antimicrobial Agents and Chemotherapy|November 4, 2009
Dose escalation study of the safety, tolerability, and pharmacokinetics of nemonoxacin (TG-873870), a novel potent broad-spectrum nonfluorinated quinolone, in healthy volunteersLuke Lin, Li-Wen Chang, Cheng-Yuan Tsai, et al.
Pageof 1